Atlas Trials

A Study to Evaluate the Efficacy and Safety of Mavacamten in Chinese Adults With Symptomatic Obstructive HCM

Clinical trial NCT05174416 · COMPLETED

Trial details

NCT number
NCT05174416
Sponsor
LianBio LLC
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Obstructive Hypertrophic Cardiomyopathy
Start date
2022-01-04
Primary completion
2023-03-06
Enrollment
81

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.